Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

Open Health appoints new digital designer

May 16, 2012 Business Services, Medical Communications, Sales and Marketing Open Health

Leo Jacobs has been appointed by Open Health as a digital designer to sit within its OPEN Source team. The …
Appointment

Merck KGaA sets out savings target as staff threaten to strike

May 15, 2012 Research and Development, Sales and Marketing Merck KGaA, R&D, Serono, cuts

Merck KGaA has outlined its plan to make €300 million in savings from its Serono drugs unit, with over half …
News
abpi image

ABPI launches new NHS partnership guide

May 15, 2012 Medical Communications, Sales and Marketing ABPI, COPD, NHS, code

The Association of the British Pharmaceutical Industry has launched a new guide to explain how pharma and the NHS can …
News
GSK picture

GlaxoSmithKline to acquire Cellzome for £61 million

May 15, 2012 Research and Development, Sales and Marketing Cellzome, Domantis, GSK, R&D

GlaxoSmithKline will expand its platform technology capability with the acquisition of a chemical proteomics company.  GSK will acquire those shares …
News

Synthetic Biologics appoints Carol Reed

May 15, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Carol Reed, Synthetic

Synthetic Biologics has appointed Carol Reed as senior vice president of Clinical & Regulatory Affairs. In this position Reed will …
Appointment
Gilenya image

Gilenya to stay on US market – but with new safety warnings

May 15, 2012 Sales and Marketing EMA, FDA, Novartis, PML, gilenya

The FDA says that Novartis’ multiple sclerosis pill Gilenya should stay on the market, but has added new safety warnings …
News
yervoy image

Scottish watchdog rejects Yervoy

May 14, 2012 Sales and Marketing BMS, Cancer, NICE, SMC, Yervoy, melanoma

The Scottish Medicines Consortium is not recommending Bristol-Myers Squibb’s melanoma treatment Yervoy.  The SMC said that Yervoy (ipilimumab), which has …
News

New Quad HIV pill on track for FDA approval

May 14, 2012 Research and Development, Sales and Marketing BMS, Compera, FDA, Gilead, HIV, The Quad

Gilead Sciences’ four-in-one HIV pill has been given the thumbs up by an FDA advisory group.  The US regulator is …
News
FDA picture

Obesity drugs vie for approval as FDA panel backs lorcaserin

May 14, 2012 Research and Development, Sales and Marketing Arena, Eisai, FDA, Qnexa, lorcaserin, obesity

An FDA panel has recommended Arena’s obesity drug lorcaserin, setting up a showdown with Vivus’ Qnexa. Qnexa was recommended by an FDA panel …
News
NICE image

NICE changes its mind on Botox

May 11, 2012 Sales and Marketing Allergan, Botox, NHS, NICE

NICE is now recommending Allergan’s Botox for chronic migraines, reversing its previous decision.  The watchdog said in final draft guidance …
News

Gamification and online communities – what can pharma do?

May 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer, Facebook, Gamification, Syrum, digital marketing

Gamification is the new buzzword in digital marketing and has the potential to engage consumers more than traditional strategies. This new …
Feature
neil_weir_abpi-12

ABPI appoints new Innovation Board Chair

May 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Neil Weir, Whitehead

The senior vice president of discovery at UCB, Neil Weir, has been appointed as the next Chair of the ABPI …
Appointment
dr_jeremy_levin_web_only

Teva appoints new president and chief executive

May 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Jeremy Levin, Teva

Ex-BMS head Dr Jeremy Levin has been appointed president and chief executive of Teva.  Prior to joining Teva, Levin, who …
Appointment

Pfizer’s RA drug on course for approval

May 10, 2012 Sales and Marketing Humira, JAK inhibitor, Pfizer, RA, rheumatoid arthritis, tofacitinib

An FDA advisory committee has recommended for approval Pfizer’s new rheumatoid arthritis treatment tofacitinib.The Arthritis Advisory Committee voted 8-2 to …
News

Novo Nordisk appoints ex-Pfizer head

May 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Pfizer, Robert Clark, regulatory affairs

Robert Clark will be joining Novo Nordisk as vice president, regulatory affairs. Clark will lead Novo Nordisk’s US regulatory team, …
Appointment
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 5, 2026

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026

Laverock secures funding for gene-control platform development

June 4, 2026

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026